Aveo Pharma Escapes Investors' Cancer Drug Stock-Drop Suit
A Massachusetts federal judge has tossed a securities class action alleging biopharmaceutical company Aveo and its executives misled investors about possible federal approval of a cancer drug, saying the company "explicitly...To view the full article, register now.
Already a subscriber? Click here to view full article